ViaDerma Provides an Update to Shareholders via a Letter from the CEO

World News: . []

LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc.,(“Company”)(OTC Pink:VDRM), is pleased to announce it has posted a from President and CEO, Dr. Christopher Otiko on the Company’s website, .

The letter contains updates on future sales, Dr. Otiko’s recent trip to India as well as several other key developments.  Some of the other items in the letter include:

Additionally, the Company is announcing they are close to finalizing a sales agreement for 10,000 units per month of Vitastem with a distributor in Vietnam.

Also, ViaDerma is in early stage discussions to have their product, Viastem sold in Direct Response ads on TV, and distributed through a network of 600 Skilled Nursing Facilities in California and 5000 hospitals in the east coast.

ViaDerma President, Dr. Christopher Otiko said, “As I pointed out in my recent letter to shareholders, we are very excited about our future and our current trajectory. In spite of some minor delays, we remain optimistic this will be a very strong year for ViaDerma.”

Investor Relations

Email:  

Phone: 310-374-6111

More news and information about ViaDerma, Inc.

Published By:

Globe Newswire: 10:00 GMT Thursday 12th July 2018

Published: .

Search for other references to "viaderma" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers